Alveolar macrophages (AM) are the primary resident effector cells in the al
veolus. Leukotrienes (LT) are secreted by AM in their role as defender of t
he lung. 5-Lipoxygenase (5-LO) catalyzes the synthesis of LT in association
with 5-LO-activating protein, termed "FLAP." AM demonstrate increased 5-LO
metabolism compared to peripheral blood monocytes (PBM). Activated lymphoc
ytes release mediators which upregulate 5-LO metabolism in PBM. The lymphoc
yte population of the lung consists predominantly of CD4+ helper constituti
vely "activated" T cells. We hypothesized that mediators released by pulmon
ary CD4+ T cells may upregulate and maintain of 5-LO metabolism in PBM as t
hey enter the alveolar space and differentiate into AM. 5-LO metabolism in
AM from CD4-depleted mice demonstrated reduced LT synthesis (LTC4: 66.9 +/-
8%; LTB4 61.4 +/- 6.2% control). The decrease in 5-LO metabolism was assoc
iated with reduced FLAP (30.1 +/- 14.5% of control) and 5-LO expression (49
+/- 13.7% of control). This defect in AM 5-LO metabolism in CD4-depleted m
ice was further associated with reduced LTC4 levels in bronchoalveolar lava
ge (BAL) fluid. In summary,factors secreted constitutively by lung lymphocy
tes, in particular CD4 cells, contribute to the increased 5-LO metabolism i
n AM.